BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15865931)

  • 21. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins by in silico approaches and binding assay.
    Golestanian S; Sharifi A; Popowicz GM; Azizian H; Foroumadi A; Szwagierczak A; Holak TA; Amanlou M
    Life Sci; 2016 Jan; 145():240-6. PubMed ID: 26746660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDM2--master regulator of the p53 tumor suppressor protein.
    Momand J; Wu HH; Dasgupta G
    Gene; 2000 Jan; 242(1-2):15-29. PubMed ID: 10721693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.
    Gu J; Kawai H; Nie L; Kitao H; Wiederschain D; Jochemsen AG; Parant J; Lozano G; Yuan ZM
    J Biol Chem; 2002 May; 277(22):19251-4. PubMed ID: 11953423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 and MDM4: p53 regulators as targets in anticancer therapy.
    Toledo F; Wahl GM
    Int J Biochem Cell Biol; 2007; 39(7-8):1476-82. PubMed ID: 17499002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
    Parant J; Chavez-Reyes A; Little NA; Yan W; Reinke V; Jochemsen AG; Lozano G
    Nat Genet; 2001 Sep; 29(1):92-5. PubMed ID: 11528400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDMX regulation of p53 response to ribosomal stress.
    Gilkes DM; Chen L; Chen J
    EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability.
    Dolezelova P; Cetkovska K; Vousden KH; Uldrijan S
    FEBS Lett; 2012 Jul; 586(16):2225-31. PubMed ID: 22659184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mdm2 and MdmX involvement in human cancer.
    Berberich SJ
    Subcell Biochem; 2014; 85():263-80. PubMed ID: 25201200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 is a central node in the p53 pathway: 12 years and counting.
    Bond GL; Hu W; Levine AJ
    Curr Cancer Drug Targets; 2005 Feb; 5(1):3-8. PubMed ID: 15720184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of MDMX by sumoylation.
    Pan Y; Chen J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):702-9. PubMed ID: 15907800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the molecular mechanisms controlling activity of protein p53 in the development of new strategies in cancer therapeutics].
    Marine Ch
    Bull Mem Acad R Med Belg; 2009; 164(5-6):175-80; discussion 180-1. PubMed ID: 20666148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins.
    Yam CH; Siu WY; Arooz T; Chiu CH; Lau A; Wang XQ; Poon RY
    Cancer Res; 1999 Oct; 59(20):5075-8. PubMed ID: 10537276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation.
    Chen X; Lu W
    Chem Pharm Bull (Tokyo); 2016; 64(7):1004-8. PubMed ID: 27373663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.
    Popowicz GM; Czarna A; Holak TA
    Cell Cycle; 2008 Aug; 7(15):2441-3. PubMed ID: 18677113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development.
    Zhang Q; He X; Chen L; Zhang C; Gao X; Yang Z; Liu G
    J Pathol; 2012 Nov; 228(3):416-28. PubMed ID: 22821713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.
    Jones SN; Roe AE; Donehower LA; Bradley A
    Nature; 1995 Nov; 378(6553):206-8. PubMed ID: 7477327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx.
    Shvarts A; Bazuine M; Dekker P; Ramos YF; Steegenga WT; Merckx G; van Ham RC; van der Houven van Oordt W; van der Eb AJ; Jochemsen AG
    Genomics; 1997 Jul; 43(1):34-42. PubMed ID: 9226370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.